These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10886210)

  • 1. Essential role for T cells in human B-cell lymphoproliferative disease development in severe combined immunodeficient mice.
    Johannessen I; Asghar M; Crawford DH
    Br J Haematol; 2000 Jun; 109(3):600-10. PubMed ID: 10886210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo models for Epstein-Barr virus (EBV)-associated B cell lymphoproliferative disease (BLPD).
    Johannessen I; Crawford DH
    Rev Med Virol; 1999; 9(4):263-77. PubMed ID: 10578121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of CD8+ and CD4+ T Cell Frequencies Specific for EBV LMP1 and LMP2a Using mRNA-Transfected DCs.
    Sohn DH; Sohn HJ; Lee HJ; Lee SD; Kim S; Hyun SJ; Cho HI; Cho SG; Lee SK; Kim TG
    PLoS One; 2015; 10(5):e0127899. PubMed ID: 26023769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus, B cell lymphoproliferative disease, and SCID mice: modeling T cell immunotherapy in vivo.
    Johannessen I; Bieleski L; Urquhart G; Watson SL; Wingate P; Haque T; Crawford DH
    J Med Virol; 2011 Sep; 83(9):1585-96. PubMed ID: 21739450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBV-induced human CD8+ NKT cells suppress tumorigenesis by EBV-associated malignancies.
    Yuling H; Ruijing X; Li L; Xiang J; Rui Z; Yujuan W; Lijun Z; Chunxian D; Xinti T; Wei X; Lang C; Yanping J; Tao X; Mengjun W; Jie X; Youxin J; Jinquan T
    Cancer Res; 2009 Oct; 69(20):7935-44. PubMed ID: 19808969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
    Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
    J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBV-induced human CD8(+) NKT cells synergise CD4(+) NKT cells suppressing EBV-associated tumours upon induction of Th1-bias.
    Xiao W; Li L; Zhou R; Xiao R; Wang Y; Ji X; Wu M; Wang L; Huang W; Zheng X; Tan X; Chen L; Xiong T; Xiong J; Jin Y; Tan J; He Y
    Cell Mol Immunol; 2009 Oct; 6(5):367-79. PubMed ID: 19887050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasculitis in the Palmerston North mouse model of lupus: phenotype and cytokine production profile of infiltrating cells.
    Luzina IG; Knitzer RH; Atamas SP; Gause WC; Papadimitriou JC; Sztein MB; Storrer CE; Handwerger BS
    Arthritis Rheum; 1999 Mar; 42(3):561-8. PubMed ID: 10088780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation.
    Veronese ML; Veronesi A; D'Andrea E; Del Mistro A; Indraccolo S; Mazza MR; Mion M; Zamarchi R; Menin C; Panozzo M
    J Exp Med; 1992 Dec; 176(6):1763-7. PubMed ID: 1460431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis.
    Melgar S; Yeung MM; Bas A; Forsberg G; Suhr O; Oberg A; Hammarstrom S; Danielsson A; Hammarstrom ML
    Clin Exp Immunol; 2003 Oct; 134(1):127-37. PubMed ID: 12974765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
    Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
    J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes.
    Baiocchi RA; Caligiuri MA
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5577-81. PubMed ID: 7911241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of hu-PBL/SCID chimeras and development of EBV-related lymphomas.
    Gan RL; Lan K; Yin ZH; Wang LJ; Song Y; Yao KT
    Chin Med Sci J; 2005 Mar; 20(1):16-22. PubMed ID: 15844306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma inhibits IL-4-induced type 2 cytokine expression by CD8 T cells in vivo and modulates the anti-tumor response.
    Apte SH; Groves P; Olver S; Baz A; Doolan DL; Kelso A; Kienzle N
    J Immunol; 2010 Jul; 185(2):998-1004. PubMed ID: 20562261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection.
    Ohga S; Nomura A; Takada H; Ihara K; Kawakami K; Yanai F; Takahata Y; Tanaka T; Kasuga N; Hara T
    J Infect Dis; 2001 Jan; 183(1):1-7. PubMed ID: 11106535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation.
    Piovan E; Bonaldi L; Indraccolo S; Tosello V; Menin C; Comacchio F; Chieco-Bianchi L; Amadori A
    Leukemia; 2003 Aug; 17(8):1643-9. PubMed ID: 12886254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. IV. Differential activation of human Th1 and Th2 lymphocytes and influence of the atopic status on lymphoma development.
    Coppola V; Veronesi A; Indraccolo S; Calderazzo F; Mion M; Minuzzo S; Esposito G; Mauro D; Silvestri B; Gallo P; Falagiani P; Amadori A; Chieco-Bianchi L
    J Immunol; 1998 Mar; 160(5):2514-22. PubMed ID: 9498797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro cytokine production and growth inhibition of lymphoblastoid cell lines by CD4+ T cells from Epstein-Barr virus (EBV) seropositive donors.
    Wilson AD; Hopkins JC; Morgan AJ
    Clin Exp Immunol; 2001 Oct; 126(1):101-10. PubMed ID: 11678905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
    Piriou ER; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D
    Eur J Immunol; 2005 Mar; 35(3):796-805. PubMed ID: 15724243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.